| Dr Sanjay M Madnani, MD | |
|
300 Middletown Blvd Ste 103, Langhorne, PA 19047-3202 | |
| (215) 741-7031 | |
| (215) 741-4470 |
| Full Name | Dr Sanjay M Madnani |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 31 Years |
| Location | 300 Middletown Blvd Ste 103, Langhorne, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790730570 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oxford Valley Pain And Spine Center, Inc. | 5991880890 | 2 |
News Archive
A natural plant compound exploits a newly identified Achilles' heel in a cancer of the eye, uveal melanoma. In human cancer cells growing in the lab, the compound shuts down the overactive signaling that drives uveal melanoma cell growth, according to researchers at Washington University School of Medicine in St. Louis.
Research on the fungus that ranks as one cause of dandruff - the embarrassing nuisance that, by some accounts, afflicts half of humanity - is pointing scientists toward a much-needed new treatment for the condition's flaking and itching.
A nose job to treat a mental health problem? Teeth whitening to overcome a severe anxiety disorder? These are just two procedures that people with body dysmorphic disorder (BDD) have traditionally turned to in order to deal with body-related concerns.
It is often suggested that the results of clinical trials are affected by the fact that the patients who volunteer for a trial are more likely to take their medication effectively than those in standard care. This supposition is, however, strongly refuted in the results of a new study revealed at the British Pharmaceutical Conference in Manchester.
› Verified 6 days ago
| Entity Name | Oxford Valley Pain And Spine Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902088842 PECOS PAC ID: 5991880890 Enrollment ID: O20080317000052 |
News Archive
A natural plant compound exploits a newly identified Achilles' heel in a cancer of the eye, uveal melanoma. In human cancer cells growing in the lab, the compound shuts down the overactive signaling that drives uveal melanoma cell growth, according to researchers at Washington University School of Medicine in St. Louis.
Research on the fungus that ranks as one cause of dandruff - the embarrassing nuisance that, by some accounts, afflicts half of humanity - is pointing scientists toward a much-needed new treatment for the condition's flaking and itching.
A nose job to treat a mental health problem? Teeth whitening to overcome a severe anxiety disorder? These are just two procedures that people with body dysmorphic disorder (BDD) have traditionally turned to in order to deal with body-related concerns.
It is often suggested that the results of clinical trials are affected by the fact that the patients who volunteer for a trial are more likely to take their medication effectively than those in standard care. This supposition is, however, strongly refuted in the results of a new study revealed at the British Pharmaceutical Conference in Manchester.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sanjay M Madnani, MD 300 Middletown Blvd Ste 103, Langhorne, PA 19047-3202 Ph: (215) 741-7031 | Dr Sanjay M Madnani, MD 300 Middletown Blvd Ste 103, Langhorne, PA 19047-3202 Ph: (215) 741-7031 |
News Archive
A natural plant compound exploits a newly identified Achilles' heel in a cancer of the eye, uveal melanoma. In human cancer cells growing in the lab, the compound shuts down the overactive signaling that drives uveal melanoma cell growth, according to researchers at Washington University School of Medicine in St. Louis.
Research on the fungus that ranks as one cause of dandruff - the embarrassing nuisance that, by some accounts, afflicts half of humanity - is pointing scientists toward a much-needed new treatment for the condition's flaking and itching.
A nose job to treat a mental health problem? Teeth whitening to overcome a severe anxiety disorder? These are just two procedures that people with body dysmorphic disorder (BDD) have traditionally turned to in order to deal with body-related concerns.
It is often suggested that the results of clinical trials are affected by the fact that the patients who volunteer for a trial are more likely to take their medication effectively than those in standard care. This supposition is, however, strongly refuted in the results of a new study revealed at the British Pharmaceutical Conference in Manchester.
› Verified 6 days ago